STEFANIE D REMSON APN
Prescription History 1083981955
Nurse Practitioner in Las Vegas, NV
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for STEFANIE D REMSON APN, an active Nurse Practitioner specialist practicing in Las Vegas, NV. Our medical registry currently tracks 37 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,332 documented patient claims. Among these therapy options, the most frequently utilized medication is Biktarvy, which accounts for 210 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other NV PrescribersVs. NV Avg |
|---|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 210 | $4,211.14 | ▲ More than typical |
About Biktarvy: This combination product is used by itself to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of 3 different drugs: bictegravir, emtricitabine, and tenofovir alafenamide. Bictegravir is called an integrase strand transfer inhibitor-INSTI. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. Emtricitabine and tenofovir alafenamide are often called NRTIs. Bictegravir/emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2024, this provider wrote 210 Medicare prescriptions for Biktarvy, about 2.1 times the volume of the typical Nevada prescriber of this medication (100.8). Medicare paid an average of $4,211.14 per fill, versus $4,077.98 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 216 30-Day Fills standardized to 30-day supplies 6,480 Days of Medication total across all patients in 2024 | |||
| Ciprofloxacin Hcl | 102 | $7.00 | ▲ More than typical |
About Ciprofloxacin Hcl: This medication is used to treat a variety of bacterial infections. Show more ▾ Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A broad-spectrum antimicrobial carboxyfluoroquinoline. In 2024, this provider wrote 102 Medicare prescriptions for Ciprofloxacin Hcl, about 3.3 times the volume of the typical Nevada prescriber of this medication (31.2). Medicare paid an average of $7.00 per fill, versus $5.71 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 106 30-Day Fills standardized to 30-day supplies 1,392 Days of Medication total across all patients in 2024 | |||
| TriumeqAbacavir/Dolutegravir/Lamivudi | 98 | $4,116.77 | ▲ More than typical |
About Triumeq: This product contains 3 drugs: abacavir, dolutegravir, and lamivudine. Show more ▾ It is used to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Abacavir and lamivudine belong to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). Dolutegravir belongs to a class of drugs known as integrase inhibitors. This medication is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. A combination of abacavir/dolutegravir/lamivudine. In 2024, this provider wrote 98 Medicare prescriptions for Triumeq, about 3 times the volume of the typical Nevada prescriber of this medication (32.9). Medicare paid an average of $4,116.77 per fill, versus $3,946.45 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 106 30-Day Fills standardized to 30-day supplies 3,180 Days of Medication total across all patients in 2024 | |||
| Doxycycline Hyclate | 84 | $23.93 | ▲ More than typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 84 Medicare prescriptions for Doxycycline Hyclate, about 2.9 times the volume of the typical Nevada prescriber of this medication (29.4). Medicare paid an average of $23.93 per fill, versus $12.44 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 92 30-Day Fills standardized to 30-day supplies 2,529 Days of Medication total across all patients in 2024 | |||
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 71 | $9.81 | ▲ More than typical |
About Sulfamethoxazole-Trimethoprim: This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. Show more ▾ It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. In 2024, this provider wrote 71 Medicare prescriptions for Sulfamethoxazole-Trimethoprim, about 2.8 times the volume of the typical Nevada prescriber of this medication (25.8). Medicare paid an average of $9.81 per fill, versus $4.49 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 83 30-Day Fills standardized to 30-day supplies 1,923 Days of Medication total across all patients in 2024 | |||
| Fluconazole | 61 | $37.43 | ▲ More than typical |
About Fluconazole: Fluconazole is used to treat vaginal yeast infections. Show more ▾ It works by stopping the growth of common types of vaginal yeast (fungus). This medication belongs to a class of drugs called azole antifungals. Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS. In 2024, this provider wrote 61 Medicare prescriptions for Fluconazole, about 3 times the volume of the typical Nevada prescriber of this medication (20.5). Medicare paid an average of $37.43 per fill, versus $9.50 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 79 30-Day Fills standardized to 30-day supplies 1,459 Days of Medication total across all patients in 2024 | |||
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 50 | $4,397.45 | ▲ More than typical |
About Odefsey: This product contains 3 different medications: emtricitabine, rilpivirine, and tenofovir alafenamide. Show more ▾ It is used to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Emtricitabine and tenofovir alafenamide belong to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). Rilpivirine belongs to a class of drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTIs). Emtricitabine/rilpivirine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2024, this provider wrote 50 Medicare prescriptions for Odefsey, about 1.6 times the volume of the typical Nevada prescriber of this medication (32.1). Medicare paid an average of $4,397.45 per fill, versus $3,880.09 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 58 30-Day Fills standardized to 30-day supplies 1,740 Days of Medication total across all patients in 2024 | |||
| Rifampin | 48 | $69.53 | ▲ More than typical |
About Rifampin: This medication is used to prevent and treat tuberculosis and other bacterial infections. Show more ▾ Rifampin belongs to a class of drugs known as rifamycin antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) In 2024, this provider wrote 48 Medicare prescriptions for Rifampin, about 2.1 times the volume of the typical Nevada prescriber of this medication (23). Medicare paid an average of $69.53 per fill, versus $52.21 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 60.7 30-Day Fills standardized to 30-day supplies 1,782 Days of Medication total across all patients in 2024 | |||
| Amoxicillin | 45 | $11.91 | ≈ Typical |
About Amoxicillin: Amoxicillin is used to treat a wide variety of bacterial infections. Show more ▾ This medication is a penicillin-type antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Amoxicillin is also used with other medications to treat stomach/intestinal ulcers caused by the bacteria H. pylori and to prevent the ulcers from returning. A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration. In 2024, this provider wrote 45 Medicare prescriptions for Amoxicillin, about the same volume as the typical Nevada prescriber of this medication (42.2). Medicare paid an average of $11.91 per fill, versus $3.03 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 45 30-Day Fills standardized to 30-day supplies 1,094 Days of Medication total across all patients in 2024 | |||
| ErtapenemErtapenem Sodium | 37 | $474.01▼ below NV avg | ≈ Typical |
About Ertapenem: Ertapenem is used to prevent and treat a wide variety of bacterial infections. Show more ▾ This medication is known as a carbapenem-type antibiotic. It works by stopping the growth of bacteria. A carbapenem derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of Gram-positive and Gram-negative bacterial infections including intra-abdominal infections, acute gynecological infections, complicated urinary tract infections, skin infections, and respiratory tract infections. It is also used to prevent infection in colorectal surgery. In 2024, this provider wrote 37 Medicare prescriptions for Ertapenem, about the same volume as the typical Nevada prescriber of this medication (35.8). Medicare paid an average of $474.01 per fill, versus $499.08 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NV average for this medication. 37 30-Day Fills standardized to 30-day supplies 267 Days of Medication total across all patients in 2024 | |||
| Rosuvastatin Calcium | 36 | $7.22▼ below NV avg | ▼ Less than typical |
About Rosuvastatin Calcium: Rosuvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks. In addition to eating a proper diet (such as a low cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Talk with your doctor for more details. A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES. In 2024, this provider wrote 36 Medicare prescriptions for Rosuvastatin Calcium, about a third of the volume of the typical Nevada prescriber of this medication (115.9). Medicare paid an average of $7.22 per fill, versus $13.14 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NV average for this medication. 63 30-Day Fills standardized to 30-day supplies 1,890 Days of Medication total across all patients in 2024 | |||
| IsentressRaltegravir Potassium | 36 | $2,091.95 | ▲ More than typical |
About Isentress: Raltegravir is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Raltegravir is known as an integrase inhibitor. It blocks the virus from growing and infecting more cells. Raltegravir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. A pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION. In 2024, this provider wrote 36 Medicare prescriptions for Isentress, about 1.9 times the volume of the typical Nevada prescriber of this medication (18.9). Medicare paid an average of $2,091.95 per fill, versus $2,033.21 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36 30-Day Fills standardized to 30-day supplies 1,080 Days of Medication total across all patients in 2024 | |||
| CefuroximeCefuroxime Axetil | 35 | $8.19▼ below NV avg | ≈ Typical |
About Cefuroxime: Cefuroxime is used to treat a wide variety of bacterial infections. Show more ▾ This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS. In 2024, this provider wrote 35 Medicare prescriptions for Cefuroxime, about the same volume as the typical Nevada prescriber of this medication (35.4). Medicare paid an average of $8.19 per fill, versus $13.32 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NV average for this medication. 35 30-Day Fills standardized to 30-day supplies 260 Days of Medication total across all patients in 2024 | |||
| Azithromycin | 29 | $37.75 | ≈ Typical |
About Azithromycin: Azithromycin is used to treat a wide variety of bacterial infections. Show more ▾ It is a macrolide-type antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. In 2024, this provider wrote 29 Medicare prescriptions for Azithromycin, about 80% of the volume of the typical Nevada prescriber of this medication (36.4). Medicare paid an average of $37.75 per fill, versus $4.62 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 44 30-Day Fills standardized to 30-day supplies 1,194 Days of Medication total across all patients in 2024 | |||
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 25 | $4,347.51 | ≈ Typical |
About Genvoya: This product is used to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product contains 4 different medications: elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide. Elvitegravir is known as an integrase inhibitor. Cobicistat helps elvitegravir work better. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor; both kinds of drugs are often called NRTIs. Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. A pharmaceutical preparation of the ANTI-HIV AGENTS elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate that is used in the treatment of HIV INFECTIONS. In 2024, this provider wrote 25 Medicare prescriptions for Genvoya, about the same volume as the typical Nevada prescriber of this medication (23.2). Medicare paid an average of $4,347.51 per fill, versus $4,045.86 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25 30-Day Fills standardized to 30-day supplies 750 Days of Medication total across all patients in 2024 | |||
| Doxycycline Monohydrate | 23 | $74.78 | ▼ Less than typical |
About Doxycycline Monohydrate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 23 Medicare prescriptions for Doxycycline Monohydrate, about 70% of the volume of the typical Nevada prescriber of this medication (33). Medicare paid an average of $74.78 per fill, versus $16.23 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 29 30-Day Fills standardized to 30-day supplies 847 Days of Medication total across all patients in 2024 | |||
| Linezolid | 22 | $59.45▼ below NV avg | ≈ Typical |
About Linezolid: Linezolid is an antibiotic used to treat certain serious bacterial infections. Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Linezolid also belongs to a class of drugs known as MAO inhibitors. It can increase the levels of certain natural substances in the body (such as dopamine, norepinephrine, serotonin) which can increase the chance of certain side effects and food and drug interactions. See How to Use, Side Effects, and Drug Interactions sections for more details. An oxazolidinone and acetamide derived ANTI-BACTERIAL AGENT and PROTEIN SYNTHESIS INHIBITOR that is used in the treatment of GRAM-POSITIVE BACTERIAL INFECTIONS of the skin and respiratory tract. In 2024, this provider wrote 22 Medicare prescriptions for Linezolid, about the same volume as the typical Nevada prescriber of this medication (21.2). Medicare paid an average of $59.45 per fill, versus $87.55 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NV average for this medication. 22 30-Day Fills standardized to 30-day supplies 248 Days of Medication total across all patients in 2024 | |||
| Ethambutol Hcl | 21 | $61.59 | ≈ Typical |
About Ethambutol Hcl: Ethambutol is used with other medications to treat tuberculosis (TB). Show more ▾ Ethambutol is an antibiotic and works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863) In 2024, this provider wrote 21 Medicare prescriptions for Ethambutol Hcl, about 75% of the volume of the typical Nevada prescriber of this medication (28.0). Medicare paid an average of $61.59 per fill, versus $43.84 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 31.6 30-Day Fills standardized to 30-day supplies 940 Days of Medication total across all patients in 2024 | |||
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $13.23 | ▼ Less than typical |
About Amoxicillin-Clavulanate Potass: Amoxicillin/clavulanic acid is a combination penicillin-type antibiotic used to treat a wide variety of bacterial infections. Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2024, this provider wrote 21 Medicare prescriptions for Amoxicillin-Clavulanate Potass, about 73% of the volume of the typical Nevada prescriber of this medication (29). Medicare paid an average of $13.23 per fill, versus $8.39 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21 30-Day Fills standardized to 30-day supplies 261 Days of Medication total across all patients in 2024 | |||
| Abacavir-LamivudineAbacavir Sulfate/Lamivudine | 20 | $53.39▼ below NV avg | ▲ More than typical |
About Abacavir-Lamivudine: This product contains 2 drugs: abacavir and lamivudine. Show more ▾ It is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Abacavir and lamivudine both belong to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). Abacavir/lamivudine is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. Combination of Epivir and Ziagen. In 2024, this provider wrote 20 Medicare prescriptions for Abacavir-Lamivudine, about 1.4 times the volume of the typical Nevada prescriber of this medication (14.8). Medicare paid an average of $53.39 per fill, versus $315.63 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NV average for this medication. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2024 | |||
| Clindamycin Hcl | 20 | $40.67 | ≈ Typical |
About Clindamycin Hcl: Clindamycin is used to treat a wide variety of bacterial infections. Show more ▾ It is an antibiotic that works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. An antibacterial agent that is a semisynthetic analog of LINCOMYCIN. In 2024, this provider wrote 20 Medicare prescriptions for Clindamycin Hcl, about 88% of the volume of the typical Nevada prescriber of this medication (22.9). Medicare paid an average of $40.67 per fill, versus $7.50 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 32 30-Day Fills standardized to 30-day supplies 850 Days of Medication total across all patients in 2024 | |||
| Levofloxacin | 19 | $4.39▼ below NV avg | ≈ Typical |
About Levofloxacin: Levofloxacin is used to treat a variety of bacterial infections. Show more ▾ This medication belongs to a class of drugs known as quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. The L-isomer of Ofloxacin. In 2024, this provider wrote 19 Medicare prescriptions for Levofloxacin, about 78% of the volume of the typical Nevada prescriber of this medication (24.2). Medicare paid an average of $4.39 per fill, versus $5.23 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NV average for this medication. 19 30-Day Fills standardized to 30-day supplies 167 Days of Medication total across all patients in 2024 | |||
| Daptomycin | 18 | $3,149.65 | ▼ Less than typical |
About Daptomycin: This medication is an antibiotic used to treat serious bacterial infections. Show more ▾ It works by stopping the growth of bacteria. Daptomycin is not recommended for use in children younger than 12 months due to possible risk of serious side effects. A cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA. In 2024, this provider wrote 18 Medicare prescriptions for Daptomycin, about a third of the volume of the typical Nevada prescriber of this medication (45.9). Medicare paid an average of $3,149.65 per fill, versus $1,613.35 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18 30-Day Fills standardized to 30-day supplies 127 Days of Medication total across all patients in 2024 | |||
| MounjaroTirzepatide | 18 | $1,025.30▼ below NV avg | ▼ Less than typical |
About Mounjaro: Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. It lowers blood sugar by causing the release of your body's natural insulin and decreasing the amount of sugar your liver makes. An analog of GASTRIC INHIBITORY POLYPEPTIDE and agonist of GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR and GLUCAGON-LIKE PEPTIDE-1 RECEPTOR used to enhance glycemic control of TYPE 2 DIABETES MELLITUS. In 2024, this provider wrote 18 Medicare prescriptions for Mounjaro, about a third of the volume of the typical Nevada prescriber of this medication (48.3). Medicare paid an average of $1,025.30 per fill, versus $1,314.63 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NV average for this medication. 18 30-Day Fills standardized to 30-day supplies 512 Days of Medication total across all patients in 2024 | |||
| GammakedImmune Globul G/Gly/Iga Avg 46 | 17 | $6,075.08▼ below NV avg | ▼ Less than typical |
About Gammaked: This medication is used in people with a certain type of weakened immune system (primary immune deficiency) to strengthen it and to lower the risk of infection. Show more ▾ This medication is made from human blood that has a high level of antibodies which help fight infections. This product is also used to increase the number of certain blood cells (platelets) in people with a certain blood disorder (idiopathic thrombocytopenic purpura-ITP). Platelets are needed to stop bleeding and to form normal blood clots. In addition, this medication is used to treat a certain nerve disorder (chronic inflammatory demyelinating polyneuropathy-CIDP). This disorder causes weakness and numbness/tingling/pain in the arms and legs. This medication helps to improve these symptoms and prevents relapse. In 2024, this provider wrote 17 Medicare prescriptions for Gammaked, about 60% of the volume of the typical Nevada prescriber of this medication (28.1). Medicare paid an average of $6,075.08 per fill, versus $10,483.40 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NV average for this medication. 17 30-Day Fills standardized to 30-day supplies 238 Days of Medication total across all patients in 2024 | |||
| Minocycline Hcl | 17 | $56.05 | ▼ Less than typical |
About Minocycline Hcl: Minocycline is used to treat a wide variety of infections. Show more ▾ It may also be used along with other medications to treat severe acne. This medication belongs to a class of drugs known as tetracycline antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections. In 2024, this provider wrote 17 Medicare prescriptions for Minocycline Hcl, about 67% of the volume of the typical Nevada prescriber of this medication (25.4). Medicare paid an average of $56.05 per fill, versus $26.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25 30-Day Fills standardized to 30-day supplies 622 Days of Medication total across all patients in 2024 | |||
| Ondansetron OdtOndansetron | 17 | $18.59 | ▼ Less than typical |
About Ondansetron Odt: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 17 Medicare prescriptions for Ondansetron Odt, about 68% of the volume of the typical Nevada prescriber of this medication (25.1). Medicare paid an average of $18.59 per fill, versus $14.92 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23 30-Day Fills standardized to 30-day supplies 644 Days of Medication total across all patients in 2024 | |||
| Darunavir | 16 | $1,585.12 | – No State Data |
About Darunavir: This drug is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Darunavir belongs to a class of drugs known as protease inhibitors. Darunavir must be given with certain other medications (such as cobicistat, ritonavir) to increase ("boost") the levels of darunavir. This helps darunavir work better. Darunavir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. This medication is not recommended for use in children younger than 3 years due to the increased risk of serious side effects. An HIV PROTEASE INHIBITOR that is used in the treatment of AIDS and HIV INFECTIONS. Due to the emergence of ANTIVIRAL DRUG RESISTANCE when used alone, it is administered in combination with other ANTI-HIV AGENTS. In 2024, this provider wrote 16 Medicare prescriptions for Darunavir. Medicare paid an average of $1,585.12 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $1,585.12 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16 30-Day Fills standardized to 30-day supplies 480 Days of Medication total across all patients in 2024 | |||
| TivicayDolutegravir Sodium | 15 | $2,482.25 | ▼ Less than typical |
About Tivicay: Dolutegravir is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Dolutegravir belongs to a class of drugs known as integrase inhibitors. It blocks the virus from growing and infecting more cells. Dolutegravir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. An HIV integrase inhibitor that is used in the treatment of HIV INFECTIONS in combination with other ANTI-HIV AGENTS. In 2024, this provider wrote 15 Medicare prescriptions for Tivicay, about a quarter of the volume of the typical Nevada prescriber of this medication (60.9). Medicare paid an average of $2,482.25 per fill, versus $2,372.95 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2024 | |||
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $14.25▼ below NV avg | ▼ Less than typical |
About Nitrofurantoin Mono-Macro: This medication is an antibiotic used to treat bladder infections (acute cystitis). Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. This medication should not be used in infants younger than 1 month old (see also Precautions section). This drug should not be used to treat infections outside the bladder (including kidney infections such as pyelonephritis or perinephric abscesses). In 2024, this provider wrote 15 Medicare prescriptions for Nitrofurantoin Mono-Macro, about half the volume of the typical Nevada prescriber of this medication (26.6). Medicare paid an average of $14.25 per fill, versus $14.31 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NV average for this medication. 15 30-Day Fills standardized to 30-day supplies 121 Days of Medication total across all patients in 2024 | |||
| Fosfomycin Tromethamine | 14 | $155.75▼ below NV avg | ▼ Less than typical |
About Fosfomycin Tromethamine: This medication is an antibiotic used to treat bladder infections (such as acute cystitis or lower urinary tract infections) in women. Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Fosfomycin should not be used to treat infections outside the bladder (such as kidney infections). An antibiotic produced by Streptomyces fradiae. In 2024, this provider wrote 14 Medicare prescriptions for Fosfomycin Tromethamine, about half the volume of the typical Nevada prescriber of this medication (30.1). Medicare paid an average of $155.75 per fill, versus $211.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NV average for this medication. 14 30-Day Fills standardized to 30-day supplies 109 Days of Medication total across all patients in 2024 | |||
| Fosamprenavir Calcium | 13 | $829.58 | – No State Data |
About Fosamprenavir Calcium: This drug is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Fosamprenavir belongs to a class of drugs known as protease inhibitors. It may be given with ritonavir, another protease inhibitor, to increase ("boost") the levels of fosamprenavir. This helps fosamprenavir work better. Fosamprenavir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. A prodrug of the protease inhibitor amprenavir. In 2024, this provider wrote 13 Medicare prescriptions for Fosamprenavir Calcium. Medicare paid an average of $829.58 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $829.58 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2024 | |||
| Escitalopram Oxalate | 13 | $8.50▼ below NV avg | ▼ Less than typical |
About Escitalopram Oxalate: This medication is used to treat certain mental/mood disorders (such as depression, anxiety). Show more ▾ Escitalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. S-enantiomer of CITALOPRAM. Belongs to a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder. In 2024, this provider wrote 13 Medicare prescriptions for Escitalopram Oxalate, about a third of the volume of the typical Nevada prescriber of this medication (42.3). Medicare paid an average of $8.50 per fill, versus $10.28 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NV average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2024 | |||
| Isoniazid | 12 | $4.11▼ below NV avg | ▼ Less than typical |
About Isoniazid: Isoniazid is used with other medications to treat active tuberculosis (TB) infections. Show more ▾ It is also used alone to prevent active TB infections in people who may be infected with the bacteria (people with positive TB skin test). Isoniazid is an antibiotic and works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. In 2024, this provider wrote 12 Medicare prescriptions for Isoniazid, about half the volume of the typical Nevada prescriber of this medication (21). Medicare paid an average of $4.11 per fill, versus $6.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NV average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| Vancomycin Hcl | 12 | $145.72 | ▼ Less than typical |
About Vancomycin Hcl: Vancomycin is used to treat a certain intestinal condition (colitis) that may rarely happen after treatment with antibiotics. Show more ▾ This condition causes diarrhea and stomach/abdominal discomfort or pain. When vancomycin is taken by mouth, it stays in the intestines to stop the growth of bacteria that cause these symptoms. This antibiotic treats only bacterial infection in the intestines. It will not work for bacterial infections in any other part of the body or for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. In 2024, this provider wrote 12 Medicare prescriptions for Vancomycin Hcl, about 74% of the volume of the typical Nevada prescriber of this medication (16.2). Medicare paid an average of $145.72 per fill, versus $119.81 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19.4 30-Day Fills standardized to 30-day supplies 416 Days of Medication total across all patients in 2024 | |||
| DescovyEmtricitabine/Tenofov Alafenam | 11 | $2,946.63 | ▼ Less than typical |
About Descovy: This product is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of two different drugs: emtricitabine and tenofovir alafenamide. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. They are often called NRTIs. This product should not be used by itself to help control HIV infection. Doing so can make your treatment less effective. Use combination treatment with at least one other HIV medication. This product is also approved in the US to help prevent HIV infection in people who have a high risk for infection. Some things that increase risk include having a partner infected with HIV, having unprotected sex, having multiple sex partners, infection with a sexually transmitted disease-STD, or use/abuse of drugs or alcohol. Emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2024, this provider wrote 11 Medicare prescriptions for Descovy, about a third of the volume of the typical Nevada prescriber of this medication (33.2). Medicare paid an average of $2,946.63 per fill, versus $2,278.28 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2024 | |||
| Breo ElliptaFluticasone/Vilanterol | 11 | $391.43▼ below NV avg | ▼ Less than typical |
About Breo Ellipta: This medication is used to prevent and decrease symptoms (wheezing and trouble breathing) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). Show more ▾ This inhaler contains 2 medications: fluticasone and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. Vilanterol belongs to a class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. When used alone, long-acting beta agonists (like vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2024, this provider wrote 11 Medicare prescriptions for Breo Ellipta, about a third of the volume of the typical Nevada prescriber of this medication (30.5). Medicare paid an average of $391.43 per fill, versus $561.62 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NV prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NV average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for STEFANIE D REMSON APN is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Nurse Practitioner prescribing approach at this Las Vegas, NV practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NV prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
